L&C Bio Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.14%

L&C Bio Co. Ltd (290650) has an Asset Resilience Ratio of 2.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 290650 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

₩10.66 Billion

≈ $7.23 Million USD Cash + Short-term Investments

Total Assets

₩497.94 Billion

≈ $337.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how L&C Bio Co. Ltd's Asset Resilience Ratio has changed over time. See L&C Bio Co. Ltd (290650) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down L&C Bio Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of L&C Bio Co. Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.66 Billion	2.14%
Total Liquid Assets	₩10.66 Billion	2.14%

Asset Resilience Insights

Limited Liquidity: L&C Bio Co. Ltd maintains only 2.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

L&C Bio Co. Ltd Industry Peers by Asset Resilience Ratio

Compare L&C Bio Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for L&C Bio Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for L&C Bio Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	5.08%	₩24.14 Billion ≈ $16.36 Million	₩475.60 Billion ≈ $322.31 Million	-17.50pp
2023-12-31	22.57%	₩59.19 Billion ≈ $40.11 Million	₩262.23 Billion ≈ $177.71 Million	+16.41pp
2022-12-31	6.17%	₩12.32 Billion ≈ $8.35 Million	₩199.73 Billion ≈ $135.35 Million	-12.10pp
2021-12-31	18.27%	₩19.62 Billion ≈ $13.30 Million	₩107.40 Billion ≈ $72.78 Million	-15.67pp
2020-12-31	33.94%	₩27.34 Billion ≈ $18.53 Million	₩80.58 Billion ≈ $54.60 Million	-9.72pp
2019-12-31	43.66%	₩28.91 Billion ≈ $19.59 Million	₩66.23 Billion ≈ $44.88 Million	-20.10pp
2018-12-31	63.76%	₩36.58 Billion ≈ $24.79 Million	₩57.38 Billion ≈ $38.88 Million	+31.65pp
2017-12-31	32.11%	₩6.58 Billion ≈ $4.46 Million	₩20.49 Billion ≈ $13.89 Million	+7.35pp
2016-12-31	24.76%	₩3.88 Billion ≈ $2.63 Million	₩15.66 Billion ≈ $10.61 Million	--

pp = percentage points

About L&C Bio Co. Ltd

KQ:290650 Korea Medical Devices

Market Cap

$1.05 Billion

₩1.56 Trillion KRW

Market Cap Rank

#8872 Global

#250 in Korea

Share Price

₩63200.00

Change (1 day)

-9.59%

52-Week Range

₩22400.00 - ₩118300.00

All Time High

₩118300.00